Robert A. Schwartz | |
---|---|
Member of the Presidential Advisory Council on HIV/AIDS | |
Assumed office March 14, 2019 | |
President | Donald Trump |
Member of the Rutgers University Board of Trustees | |
Assumed office July 1,2014 1 | |
Preceded by | Asha Samant |
Personal details | |
Born | Robert Allen Schwartz June 30,1947 Oakland,California,U.S. |
Spouse(s) | Camila Krysicka Janniger (m. 1984–present) |
Children | Edmund Janniger |
Residence | Englewood,New Jersey |
Alma mater | University of California,Berkeley (BA) University of California,Berkeley School of Public Health (MPH) New York Medical College (MD) |
Profession | Physician Biomedical researcher university professor |
Website | Official website |
1. As Faculty Representative [1] | |
Robert Allen Schwartz FRCP Edin (born June 30,1947) is an American physician,biomedical researcher,university professor,and government official. He is Professor and Head of Dermatology,Professor of Medicine,Professor of Pediatrics,and Professor of Preventive Medicine and Community Health at the Rutgers New Jersey Medical School,Visiting Professor and Scholar of Public Affairs and Administration at the Rutgers School of Public Affairs and Administration,and serves on the Rutgers University Board of Trustees. He has made seminal contributions to medicine,including the discovery of AIDS-associated Kaposi sarcoma (KS-AIDS) and Schwartz–Burgess syndrome. In 2019 Schwartz joined the Trump administration as a member of the Presidential Advisory Council on HIV/AIDS.
He earned a Bachelor of Arts in political science at the University of California,Berkeley in 1969,a Master of Public Health at the University of California,Berkeley School of Public Health in 1970,and a Doctor of Medicine at the New York Medical College in 1974,from which he graduated at the top of his class as a member of the Alpha Omega Alpha Honor Medical Society. He trained in dermatology at the University of Cincinnati and at Roswell Park Comprehensive Cancer Center. He advanced in academia,from the University of Arizona and the University of California,San Francisco,to the Rutgers New Jersey Medical School,where in 1983 he became the first permanent head of dermatology,establishing a dermatology residency program in 1984.
In 1981 Schwartz led one of the three groups that first described AIDS-associated Kaposi sarcoma (KS-AIDS). In 1978 he first described florid cutaneous papillomatosis. Schwartz is credited with the clinical description of new subtypes of Kaposi's sarcoma:telangiectatic Kaposi's sarcoma,keloidal Kaposi's sarcoma and ecchymotic Kaposi’s sarcoma. In 1981 he first described acral acanthotic anomaly (acral acanthosis nigricans). In 1980 Edmund Klein,Schwartz and associates published in Cancer one of the first effective treatments of Kaposi’s sarcoma,a type of cancer that became more frequent as the AIDS epidemic unfolded.
Schwartz has authored several books,including Skin Cancer:Recognition and Management ,a leading book on cutaneous oncology currently in its second edition. Schwartz has also written 10 monographs,and is the author of over 250 book chapters,500 articles,and 200 other publications. He has lectured in more than 30 different countries and,for eighteen consecutive years,was on the faculty of the annual meeting of the American Academy of Dermatology. Schwartz has been elected an honorary member of more than 20 national dermatologic societies. He has received multiple honorary doctorates.
Robert Allen Schwartz was born on June 30,1947,in Oakland,California. He spent his four undergraduate years at the University of California,Berkeley,graduating with a Bachelor of Arts in political science in 1969. He remained there to earn a Master of Public Health degree in 1970 from the University of California,Berkeley School of Public Health. He then matriculated into the New York Medical College in Manhattan,from which he graduated as a member of the Alpha Omega Alpha Honor Medical Society in 1974. He trained in dermatology at the University of Cincinnati College of Medicine and at Roswell Park Comprehensive Cancer Center. He later completed a fellowship in dermatopathology. Schwartz is board certified in dermatology and in diagnostic and laboratory immunology.
Schwartz advanced in academia,from the University of Arizona and the University of California,San Francisco to the Rutgers New Jersey Medical School,where in 1983 he became the first permanent head of dermatology,establishing a dermatology residency program in 1984. He is Professor and Dead of dermatology,Professor of Medicine,Professor of Pediatrics,and Professor of Preventive Medicine and Community Health at the Rutgers New Jersey Medical School. He is a Visiting Professor and Scholar of Public Affairs and Administration at the Rutgers School of Public Affairs and Administration. [2] In 2014 Schwartz began serving on the Rutgers University Board of Trustees. [1]
Schwartz is also in his second term as President of the World Health Academy,serving from 2011 to 2012 and 2014 to present,and has been active on National Institutes of Health study sections since 2004. [3] Schwartz has served as Faculty President of the Rutgers New Jersey Medical School in 1993 and 1995 and as Chairman of its Committee on Appointments and Promotions twice.
He has been involved in many campus activities,including as Sigma Xi Scientific Research Society chapter president and Alpha Omega Alpha National Honor Society chapter councilor. He received the Faculty of the Year Award at the Rutgers New Jersey Medical School in 2002 and has been chosen as Top Doctor multiple times by New York Magazine , Inside Jersey ,and Castle-Conolly Guide to Best Physicians. A two-time past president of the Dermatology Section of the New York Academy of Medicine,he has been elected to a third five-year term on the Board of Directors of the International Society of Dermatology.
Schwartz has authored several books,most recently Skin Cancer:Recognition and Management ,a leading book on cutaneous oncology currently in its second edition. He has written or edited 10 monographs,and is the author of over 250 book chapters,500 articles,and 200 other publications. Many of these are in the area of dermatologic oncology,where he has had a special interest in epidermal tumors,paraneoplastic syndromes,and Kaposi’s sarcoma. He has published more than 50 full articles on Kaposi’s sarcoma since 1978,including one of the first three reports of KS-AIDS in 1981. [4] [5] [6] [7] He was the first to describe many Kaposi's sarcoma morphologic variants. [8] [9] [10] [11] In 1978 he first described florid cutaneous papillomatosis. [12] In 1981 he discovered and described acral acanthosis nigricans. [13] [14] [15] In 1994 he devised the commonly-accepted classification for acanthosis nigricans. [16] [17]
He has served as editor of the Acta Dermatovenerologica Alpina Panonica Adriatica,assistant editor of the Journal of the American Academy of Dermatology ,associate editor of Cutis and Acta Dermatovenerologica Croatica,deputy editor of Mycoses ,contributing editor of Dermatologic Surgery,and section editor of the Journal of Surgical Oncology. He is a member of the editorial boards of numerous journals,including American Family Physician ,Anais Brasileiros de Dermatologia, International Journal of Dermatology ,Indian Journal of Dermatology,Venereology and Leprology,Indian Journal of Dermatology,Giornale Italiano di Dermatologia e Venereologia,Postępy Dermatologii i Alergologii,Journal of the European Academy of Dermatology and Venereology,and Cesko-SlovenskáDermatologie.
Schwartz joined the Trump administration as a member of the Presidential Advisory Council on HIV/AIDS in 2019. [18]
A partial list of Schwartz's honors and awards.
Award or decoration | Country | Date | Place | Note | Ref |
---|---|---|---|---|---|
Hieronymus Fracastorus Medal | Italy | 2003 | Capri | Awarded at the 31st Italian National Congress. | [2] |
Academia Medica Wratislaviensis Polonia Medal | Poland | 2007 | Wrocław | The highest award bestowed by Wrocław Medical University. | [2] |
Stefan G. Nicolau Medal | Romania | 2008 | Bucharest | The highest award given by the Romanian Society of Dermatology. | [2] |
International Corresponding Membership in the Amazonian Academy of Medicine | Brazil | 2010 | Manaus | [19] | |
Amazonian Academy of Medicine Medal | Brazil | 2010 | Manaus | The highest award given by the Amazonian Academy of Medicine. | [19] |
Institution | Degree | Location | Date | Note | Ref |
---|---|---|---|---|---|
Tbilisi Medical Academy | Doctor of Science | Tbilisi, Georgia | 2013 | "for his important contributions to the field of medicine, including original work in the acquired immune deficiency syndrome (AIDS) and Kaposi's sarcoma." | [20] |
China Medical University | hon. prof. | Shenyang, China | 2012 | Conferred by the CMU president in an official ceremony. | [21] |
In 1984, Schwartz married Camila Krysicka, a dermatologist and academic. Their son Edmund Janniger was an advisor to Polish Defence Minister Antoni Macierewicz for a short period of time in 2015. [22]
Acanthosis nigricans is a medical sign characterised by brown-to-black, poorly defined, velvety hyperpigmentation of the skin. It is usually found in body folds, such as the posterior and lateral folds of the neck, the armpits, groin, navel, forehead and other areas.
Kaposi's sarcoma-associated herpesvirus (KSHV) is the ninth known human herpesvirus; its formal name according to the International Committee on Taxonomy of Viruses (ICTV) is Human gammaherpesvirus 8, or HHV-8 in short. Like other herpesviruses, its informal names are used interchangeably with its formal ICTV name. This virus causes Kaposi's sarcoma, a cancer commonly occurring in AIDS patients, as well as primary effusion lymphoma, HHV-8-associated multicentric Castleman's disease and KSHV inflammatory cytokine syndrome. It is one of seven currently known human cancer viruses, or oncoviruses. Even after many years since the discovery of KSHV/HHV8, there is no known cure for KSHV associated tumorigenesis.
Moritz Kaposi was a physician and dermatologist from the Austro-Hungarian Empire who discovered the skin tumor that received his name.
Yuan Chang is a Taiwanese-born American virologist and pathologist who co-discovered together with her husband, Patrick S. Moore, the Kaposi's sarcoma-associated herpesvirus (KSHV) and Merkel cell polyomavirus, two of the seven known human oncoviruses.
Marcus Augustine Conant is an American dermatologist and one of the first physicians to diagnose and treat Acquired Immune Deficiency Syndrome (AIDS) in 1981. He helped create one of the largest private AIDS clinics, was a founder of the San Francisco AIDS Foundation, and his work contributed to development of some of today's top HIV medications. He has written over 70 publications on the treatment of AIDS.
Skin Cancer: Recognition and Management is a clinical reference by Robert A. Schwartz covering skin and accessible mucosal disorders, premalignant and malignant cutaneous disorders, including melanoma, Kaposi's sarcoma and other sarcomas, cutaneous lymphoma, cutaneous metastatic disease and cutaneous markers of internal malignancy. It emphasizes skin cancer prevention, as well as recent advances in diagnosis and management. It has a chapter exploring dermoscopic evaluation of skin cancer and a chapter on oral cancer.
Florid cutaneous papillomatosis (FCP) is an obligate paraneoplastic syndrome.
Kaposi's sarcoma (KS) is a type of cancer that can form masses on the skin, in lymph nodes, in the mouth, or in other organs. The skin lesions are usually painless, purple and may be flat or raised. Lesions can occur singly, multiply in a limited area, or may be widespread. Depending on the sub-type of disease and level of immune suppression, KS may worsen either gradually or quickly. Except for Classical KS where there is generally no immune suppression, KS is caused by a combination of immune suppression and infection by Human herpesvirus 8.
Targetoid hemosiderotic hemangioma, also known as a hobnail hemangioma is a skin condition characterized by a central brown or purplish papule that is surrounded by an ecchymotic halo. It may appear similar to melanoma. It was first described by Santa Cruz and Aronberg in 1988.
Pomalidomide, sold under the brand names Pomalyst and Imnovid, is an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma.
David J. Leffell, MD, was born in 1956 in Montreal, Canada and educated at McGill University and Yale University. He is founder and chief of the Dermatologic Surgery Program at Yale School of Medicine. Leffell is an internationally recognized expert in skin cancer and the Mohs technique, plastic reconstruction, and new technologies in dermatology. He specializes in the diagnosis, treatment, and prevention of melanoma and nonmelanoma skin cancer. He is the David Paige Smith Professor of Dermatology and Surgery, chief of Dermatologic Surgery and Cutaneous Oncology, and former Deputy Dean for Clinical Affairs at Yale University School of Medicine. In January 2012, Dr. Leffell stepped down as chief executive officer of the Yale Medical Group, after 15 years of leadership of the organization. He serves on the board of Validus Pharmaceuticals and is a trustee of The Hopkins School, one of America's oldest independent schools.
Oral pigmentation is asymptomatic and does not usually cause any alteration to the texture or thickness of the affected area. The colour can be uniform or speckled and can appear solitary or as multiple lesions. Depending on the site, depth, and quantity of pigment, the appearance can vary considerably.
Arnold William Klein was an American dermatologist.
Tripe palms, also known as acanthosis palmaris, is a medical sign characterized by thick ridged velvety palms, typically as part of a paraneoplastic syndrome. It resembles the lining of the stomach of some animals (tripe). Other signs that may be noted at the same time include most frequently acanthosis nigricans (AN), and less commonly finger clubbing and Leser-Trélat sign.
Multinucleate cell angiohistiocytoma (MCAH) is a cutaneous condition that presents as slowly growing, multiple, discrete but grouped, red to violaceous papules
Michael Stuart Gottlieb is an American physician and immunologist known for his 1981 identification of acquired immune deficiency syndrome (AIDS) as a new disease, and for his HIV/AIDS research, HIV/AIDS activism, and philanthropic efforts associated with HIV/AIDS treatment.
Linda Jane Laubenstein was an American physician and early HIV/AIDS researcher. She was among the first doctors in the United States to recognize the AIDS epidemic of the early 1980s; she co-authored the first article linking AIDS with Kaposi's sarcoma.
Dean Hamilton Kedes is an American scientist in the field of virology and former director of the medical scientist training program at the University of Virginia school of medicine.
Miguel A. Sanchez is a board-certified pathologist who specializes in anatomic pathology, clinical pathology and cytopathology. Sanchez is chief of pathology and medical director of The Leslie Simon Breast Care and Cytodiagnosis Center at Englewood Hospital and Medical Center in Englewood, New Jersey. He is best known for his contribution in setting the standards of diagnosis and treatment of breast and thyroid disease praised by the United States Congress in 1994.
Stephen Porter is Director of UCL Eastman Dental Institute where he has been Professor of Oral Medicine since 1997. He is a consultant in Oral Medicine at University College Hospital, London and a member of the Faculty of Dental Surgery of the Royal College of Surgeons. Porter has published more than 450 scholarly works, including the scientific journals The BMJ, The British Dental Journal and The Journal of the American Dental Association.